"The Center for Cancer and Blood Disorders (CCBD) at Phoenix Children’s is the largest pediatric program of its kind in Arizona, providing complete care for children diagnosed with malignancies and blood diseases. Our family-centered approach gives our team the focus needed to provide purposeful, compassionate and personalized care to every single one of our patients. Each child gets their very own team of physicians, nurses, social workers, physical therapists, nutritionists and more — a team that provides care during treatment and throughout the healing process."

During the past decade, Phoenix Children's Hospital Center for Cancer and Blood Disorders conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Phoenix Children's Hospital Center for Cancer and Blood Disorders" #1 collaborator was "Children's Oncology Group" with 1 trials as a collaborator, "EsPhALL" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator, "Pediatric Oncology Experimental Therapeutics Investigators' Consortium" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Phoenix Children's Hospital Center for Cancer and Blood Disorders" are "Acute Lymphoblastic Leukemia" (1 trials), "Astrocytoma" (1 trials), "Glioma" (1 trials), "Leukemia, Pediatric" (1 trials) and "Low-grade Glioma" (1 trials). Many other conditions were trialed in "Phoenix Children's Hospital Center for Cancer and Blood Disorders" in a lesser frequency.

Most popular intervention types in "Phoenix Children's Hospital Center for Cancer and Blood Disorders" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Dasatinib" (1 trials), "L-glutamine" (1 trials), "No systemic anticoagulant prophylaxis" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Phoenix Children's Hospital Center for Cancer and Blood Disorders" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Phoenix Children's Hospital Center for Cancer and Blood Disorders". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Phoenix Children's Hospital Center for Cancer and Blood Disorders, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Phoenix Children's Hospital Center for Cancer and Blood Disorders, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".